Medlab Clinical Ltd. announced that an agreement has been signed with Australian Pharmaceutical Industries (API) to range Medlab's nutraceutical range in Priceline Pharmacy. As part of the agreement API will also hold Medlab products in its warehouses, significantly expanding potential distribution to more than 2,100 independent pharmacies who will now be able to easily access the product range, fulfilling a key priority from the 2018 Medlab AGM. The agreement positions Medlab's nutraceutical range into professional pharmacy with onboarding expected to take 3-4 months.

It is anticipated these agreements will result in a substantial increase in sales in the 12 month period from official launch. The agreement positions Medlab's nutraceutical range into professional pharmacy with onboarding expected to take 3-4 months. It is anticipated these agreements will result in a substantial increase in sales in the 12 month period from official launch.

Medlab's nutraceutical offering differs from general retail due to its exposure to clinical research and patents. Medlab currently has 27 patents covering a large number of the products in the nutraceutical range. Included within the range are NanoCelleTM products which were developed using Medlab's patented delivery platform.